| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| COHORT A: Unequivocal evidence of new and/or progressive brain metastases, and at least one of the following scenarios | Inclusion | Brain Metastases | None | None | (Scenario 1) |
|  |  |  |  |  | (Scenario 2) |
|  |  |  |  |  | (Scenario 3) |

Scenario 1:
(1) Unequivocal evidence of new and/or progressive brain metastases and Karnofsky performance status (KPS) ≥70%

Scenario 2:
(2) Unequivocal evidence of new and/or progressive brain metastases and systemic treatment naïve for brain metastases

Scenario 3:
(3) Unequivocal evidence of new and/or progressive brain metastases and prior treatment with stereotactic radiosurgery (SRS) or surgical resection for brain metastases, with at least 14 days elapsed since the last treatment and KPS ≥70%

Note:

* Disease: Brain Metastases
* Biomarker: None
* Prior Therapy: Stereotactic radiosurgery (SRS) or surgical resection for brain metastases (in Scenario 3